Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Depression Clinical Trials

A listing of Depression medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (892) clinical trials

Symptoms may include: Feeling sad, blue, hopeless, or worthless Crying spells Trouble sleeping or sleeping too much Difficulty concentrating Unexplained low energy or fatigue Loss of interest or pleasure Changes in weight or appetite Wondering if life is worth living Dr. John Zajecka and other investigators at Rush University Medical ...

Phase N/A

If so, call Boston Clinical Trials at 617-477-4868 and ask about our research study of investigational medication for depression. Located in Roslindale Village.Evening appointments available.Free parking. Compensation provided. www.bostontrials.com

Phase N/A

Dr. Charles Conway is conducting a research study looking at adaptive enhanced transcranial direct current stimulation (tDCS) as adjunctive therapy for major depression. This study lasts 6 weeks. There will be up to 24 study visits that will last 30 minutes to 3 hours each. Participants will undergo 20 sessions ...

Phase N/A

The Atlanta Center for Medical Research is enrolling volunteers with major depressive episodes associated with Bipolar I or Bipolar II Disorder (Bipolar Depression) in a study testing an investigational medication.

Phase N/A

The purpose of the study is to evaluate which antidepressants work better in older adults with hard to treat depression and if it is better to augment or switch treatment. This study will last 18 months. There are up to 4 in-person visits (2-3 hours each) and 14 phone calls ...

Phase N/A

Adults experiencing depression associated with bipolar disorder have the opportunity to participate in a clinical trial studying the efficacy of a new, investigational medication. Qualified participants will receive study medication and will be closely followed by UC Health staff over 6 weeks.

Phase N/A

The purpose of this study is to test an investigational drug called SAGE-547 (Allopregnolone) to determine if it is safe and has any effect on moderate and/or severe postpartum depression. An investigational drug is one that is not approved by the United States Food and Drug Administration (FDA).

Phase N/A

This study will assess the safety and efficacy of an investigational medication in patients with Major Depressive Disorder who have had a partial response to their antidepressant treatment. Each patient will receive a weekly intravenous dose of the investigational medication in addition to the current dose of their antidepressant.

Phase N/A

This study will evaluate the efficacy, safety, and tolerability of rapastinel 450 milligrams (mg) compared to placebo adjunctive to antidepressant therapy (ADT) in patients with major depressive disorder (MDD) who have a partial response to ADT.

Phase N/A

We are currently recruiting children and adolescents between the ages of 9-17 to participate in a brain-imaging study to understand how appetite and mood are related. Through this study, we hope to learn more about the neurological systems critical for the response and regulation of reward that contribute to both ...

Phase N/A